natgillin/translations-raw huggingface dataset:
“Your doctor may need to change your dose and/or to take other precautions: If you are taking an angiotensin II receptor blocker (ARB) or aliskiren (see also information under the headings “Do not <take> <use> X” and “Warnings and precautions”)” 
Če jemljete blokator receptorjev angiotenzina II (ARB) ali aliskiren (glejte tudi informacije pod naslovoma "Ne <jemljite> <uporabljajte> zdravila X" in "Opozorila in previdnostni ukrepi")"
For candesartan-containing products with wording in section 4.1 stating that they can be used alone or in combination with other antihypertensive agents, the following cross-reference should be added: “(see sections 4.3, 4.4, 4.5 and 5.1)”. 
Pri zdravilih, ki vsebujejo kandesartan in imajo v poglavju 4.1 besedilo o tem, da jih je mogoče uporabljati same ali v kombinaciji z drugimi antihipertenzivi, je treba dodati naslednjo navzkrižno referenco: “(glejte poglavja 4.3, 4.4, 4.5 in 5.1)”.
London, 19 March 2009 Doc. 
London, 19. marca 2009 Sklic dok.
Ref. EMEA/156698/2009 
EMEA/291357/2009
The main measure of effectiveness was the how long the patients survived until the disease came back. 
Glavno merilo učinkovitosti je bilo, kako dolgo so bolniki preživeli do ponovitve bolezni.
The letter from the company notifying the EMEA of the withdrawal of the application is available here. 
Dopis družbe, s katerim agencijo EMEA obvešča o umiku vloge, je na voljo tukaj.
Following the CHMP's opinion, it usually takes around two months for the European Commission to grant a licence. 
Potem ko CHMP izda svoje mnenje, običajno traja približno dva meseca, preden Evropska komisija dovoljenje odobri.
The effects of Cylatron were first tested in experimental models before being studied in humans. 
Učinki zdravila Cylatron so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
Patients were either given Cylatron for up to five years or received no treatment. 
Bolniki so v obdobju petih let jemali zdravilo Cylatron ali pa jih niso zdravili.
Cylatron was studied in one main study involving 1,256 adults with stage III melanoma. 
Zdravilo Cylatron so proučili v eni glavni študiji, ki je vključevala 1 256 odraslih z melanomom III. stadija.
It was also concerned that, although the medicine showed some effects in delaying the return of the cancer, it had not been shown to be effective in increasing how long the patients survived. 
Prav tako je imel zadržke, da se zdravilo, kljub temu, da je pokazalo nekatere učinke pri upočasnitvi ponovitve raka, ni pokazalo kot učinkovito pri podaljšanju časa preživetja bolnikov.
This withdrawal of application has no consequences on the use of PegIntron, ViraferonPeg and IntronA in their authorised indications, for which the balance of benefits and risks remains unchanged. 
Ta umik vloge nima nobenih posledic za uporabo zdravil PegIntron, ViraferonPeg in IntronA za odobrene indikacije, pri katerih ostaja razmerje med koristmi in tveganji nespremenjeno.
Questions and answers on the withdrawal of the marketing application for Cylatron 
Vprašanja in odgovori v zvezi z umikom vloge za dovoljenje za promet z zdravilom Cylatron
This decreases the rate at which the substance is removed from the body and allows the medicine to be given less often. 
Tako se zmanjša hitrost izločanja kemične spojine iz telesa in dopušča manj pogosto jemanje zdravila.
In melanoma, interferon alfa-2b is thought to work by suppressing the growth and multiplication of cancerous cells, by causing these cells to die and by stimulating the immune system (the body's natural defences) to attack and kill the cancer cells. 
Pri melanomu naj bi interferon alfa-2b deloval z zaviranjem rasti in množenja rakastih celic, saj povzroči smrt teh celic in stimulira imunski sistem (naravno obrambo telesa), da napade in ubije rakaste celice.
Melanoma is a type of skin cancer affecting cells called melanocytes. 
Melanom je vrsta kožnega raka, ki prizadene celice, imenovane melanociti.
Peginterferon alfa-2b has been authorised in the European Union (EU) since May 2000 as PegIntron and ViraferonPeg for the treatment hepatitis C. Unpegylated interferon alfa-2b has also been authorised in the EU since March 2000 as IntronA. 
Peginterferon alfa-2b je odobren v Evropski uniji (EU) od maja 2000 kot zdravili PegIntron in ViraferonPeg za zdravljenje hepatitisa C. Prav tako je od marca 2000 v EU odobren nepegiliran interferon alfa-2b kot zdravilo IntronA.
On 11 March 2009, SP Europe officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Cylatron for the adjuvant treatment of stage III melanoma. 
Družba SP Europe je 11. marca 2009 uradno obvestila Odbor za zdravila za uporabo v humani medicini (CHMP), da želi umakniti vlogo za dovoljenje za promet z zdravilom Cylatron, namenjenim za adjuvantno zdravljenje melanoma III. stadija.
What documentation did the company present to support its application to the CHMP? 
Katero dokumentacijo je družba predložila CHMP v podporo svoji vlogi ?
What are the consequences of the withdrawal for patients undergoing clinical trials or compassionate use programmes with Cylatron? 
Kakšne so posledice umika za bolnike, ki sodelujejo v kliničnih preskušanjih ali programih sočutne uporabe zdravila Cylatron?
The CHMP had concerns over side effects of Cylatron, particularly fatigue (tiredness) and depression. 
CHMP je imel zadržke glede neželenih učinkov zdravila Cylatron, zlasti glede utrujenosti in depresije.
What is Cylatron? 
Kaj je zdravilo Cylatron?
International non-proprietary name (INN): peginterferon alfa-2b 
Mednarodno nelastniško ime (INN): peginterferon alfa-2b
Based on the review of the data and the company's response to the CHMP list of questions at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Cylatron could not have been approved for adjuvant treatment of stage III melanoma. 
Na podlagi pregleda podatkov in odgovorov družbe na seznam vprašanj, ki jih je do umika vloge zastavil CHMP, je Odbor izrazil določene zadržke in je začasno menil, da zdravila Cylatron ni mogoče odobriti za adjuvantno zdravljenje melanoma III. stadija.
‘Stage III' means that some cancer cells have spread to the lymph nodes (part of the lymphatic system that drains fluids from the body's tissues). 
stadij“ pomeni, da se je nekaj rakastih celic razširilo na bezgavke (to je del limfnega sistema, ki črpa tekočino iz telesnih tkiv).
Cylatron was expected to be used in adults with stage III (advanced) melanoma as an add-on treatment after surgery, to prevent the disease from coming back. 
Zdravilo Cylatron naj bi se uporabljalo pri odraslih z melanomom III. (napredovalega) stadija kot dodatno zdravljenje po operativnem posegu za preprečevanje ponovitve bolezni.
When the study began, all of the patients had recently had surgery to remove lymph nodes containing melanoma cells. 
Ob začetku študije bili vsi bolniki pred kratkim operirani, pri čemer so jim odstranili bezgavke z melanomskimi celicami.
The company informed the CHMP that there are no consequences for patients currently included in clinical trials or compassionate programmes with Cylatron. 
Družba je obvestila CHMP, da umik nima nobenih posledic za bolnike, ki trenutno sodelujejo v kliničnih preskušanjih ali programih sočutne uporabe zdravila Cylatron.
What is happening with PegIntron and ViraferonPeg for the treatment of hepatitis C and with IntronA for the treatment of malignant melanoma? 
Kakšne so posledice za zdravili PegIntron in VirafeornPeg, indicirani za zdravljenje hepatitisa C in kakšne za zdravilo IntronA, indicirano za zdravljenje malignega melanoma?
IntronA is authorised for the treatment of malignant melanoma after surgery, along with other diseases. 
Zdravilo IntronA je odobreno za zdravljenje malignega melanoma po operativnem posegu, skupaj z drugimi boleznimi.
Cylatron was expected to be given to patients whose lymph nodes contained melanoma cells as visible under a microscope, but not when the cancer had caused the lymph nodes to become large enough to be felt through the skin. 
Zdravilo Cylatron naj bi se dajalo bolnikom, pri katerih je vsebnost melanomskih celic v bezgavkah vidna pod mikroskopom, ne pa takrat, ko so bezgavke zaradi raka tako povečane, da se tipajo skozi kožo.
Cylatron is a powder and solvent that is made up into a solution for injection. 
Zdravilo Cylatron sestavljata prašek in topilo, ki ju zmešamo v raztopino za injiciranje.
It consists of a substance called interferon alfa-2b, which has been ‘pegylated' (coated with a chemical called polyethylene glycol). 
Sestavljen je iz snovi, imenovane interferon alfa-2b, ki je „pegilirana“ (prevlečena s kemično spojino polietilenglikol).
What was Cylatron expected to be used for? 
Za kaj naj bi se zdravilo Cylatron uporabljalo?
How is Cylatron expected to work? 
Kako naj bi zdravilo Cylatron delovalo?
It contains the active substance peginterferon alfa-2b. 
Vsebuje zdravilno učinkovino peginterferon alfa-2b.
The active substance in Cylatron, peginterferon alfa-2b, belongs to the group ‘interferons'. 
Zdravilno učinkovino zdravila Cylatron, peginterferon alfa-2b, uvrščamo v skupino „interferonov“.
EU number 
Številka EU
Invented name Strength Pharmaceutical 
Izmišljeno ime jakost farmacevtska oblika pot uporabe ovojnina velikost pakiranja
Lundbeck B.V. 
Nizozemska Lundbeck B.V.
Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, Marketing Authorisation Holders in the Member States 
Dodatek I Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe zdravila,
Modified-release capsule, hard 
75 mg kapsula s prirejenim sproščanjem, trda
Intramuscular use intravenous use 
50 mg/2 ml raztopina za injiciranje intramuskularna uporaba intravenska uporaba
Coated Tablet 
10 mg obložena tableta
Sarotex Retard 50 mg 
Saroten retard Tabs 75 mg tableta s prirejenim sproščanjem
Cyprus 
Ciper
--1 Inactivated influenza A virus/human, strain A/Jena/VI5258/2009(H1N1)pdm09 ≥ 16 HU* *HU = haemagglutinating units 
--1 Inaktivirani virus influence A (humani) Sev: A/Jena/VI5258/2009(H1N1)pdm09 ≥ 16 HU*
Annex A 
Dodatek A
EU (MA) Number Invented name 
EU (MA) številka
Package size 
Velikost pakiranja
Packaging Content 
Način uporabe Pakiranje Vsebina
United Kingdom Trading as Sterling Health or 
Velika Britanija Trading as Sterling Health or
Johnson & Johnson, Lda. 
Portugalska Johnson & Johnson, Lda.
Al. Armii Ludowej 26 00-609 Warszawa Poland 
Al. Armii Ludowej 26 00-609 Warszawa Poljska
Niepodleglosci 18 02-653 Warsaw Poland 
Niepodleglosci 18 02-653 Warsaw Poljska
2 Ellinikou Str 16777,Elliniko, Athens Greece 
2 Ellinikou Str 16777,Elliniko, Athens Grčija
26.200 28700 San Sebastián de los Reyes (Madrid) Spain 
26.200 28700 San Sebastián de los Reyes (Madrid) Španija
Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States 
Seznam imen, farmacevtskih oblik, jakosti zdravil, načinov aplikacije, imetnikov dovoljenj za promet v državah članicah
Belgium Aktuapharma nv Ambachtenlaan 13E 3001 Leuven 
Aktuapharma nv Ambachtenlaan 13E 3001 Leuven Belgija
Hameenlinna Finland 
Hameenlinna Finska
Mylan Sas 117, allée des Parcs 69800 Saint-Priest France 
Mylan Sas 117, allée des Parcs 69800 Saint-Priest Francija
13500 HÄMEENLINNA Finland 
13500 HÄMEENLINNA Finska
B-1560 Hoeilaart Belgium 
B-1560 Hoeilaart Belgija
Souffelweyersheim France 
Souffelweyersheim Francija
Teva Sante 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex France 
Teva Sante 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex Francija
Bayer Sante Familiale 33, Rue De L'industrie 74240 Gaillard France 
Bayer Sante Familiale 33, Rue De L'industrie 74240 Gaillard Francija
10237 Dolni Mecholupy Czech Republic 
10237 Dolni Mecholupy Češka
Societe Cilfa Developpement 20, Rue Jean Daudin 75015 - Paris France 
Societe Cilfa Developpement 20, Rue Jean Daudin 75015 - Paris Francija
37, rue Saint-Romain 69379 Lyon Cedex 08 France 
37, rue Saint-Romain 69379 Lyon Cedex 08 Francija
Bayer Portugal, S.A. Rua Quinta do Pinheiro 
Portugalska Bayer Portugal, S.A. Rua Quinta do Pinheiro
Chefaro Ireland Limited, First Floor, Block A, The Crescent Building, Northwood Office Park, Dublin 9, Ireland 
Chefaro Ireland Limited, First Floor, Block A, The Crescent Building, Northwood Office Park, Dublin 9, Irska
S.C. TERAPIA S.A Str. Fabricii Nr.124, Cluj-Napoca, Judeţul Cluj, 400632 
Romunija S.C. TERAPIA S.A Str. Fabricii Nr.124, Cluj-Napoca, Judeţul Cluj, 400632
92700 Colombes France 
92700 Colombes Francija
22 quai Gallieni 92150 Suresnes France 
22 quai Gallieni 92150 Suresnes Francija
69007 Lyon France 
69007 Lyon Francija
Alkaloid-Int. d.o.o. 
Slovenija Alkaloid-Int. d.o.o.
69151 Décines Cedex France 
69151 Décines Cedex Francija
Omega Pharma Baltics SIA, K. Ulmana 119, Marupe, LV-2167, Latvia 
Omega Pharma Baltics SIA, K. Ulmana 119, Marupe, LV-2167, Latvija
Denmark Amgros I/S, Dampfærgevej 22, DK-2100 København Ø, Denmark 
Amgros I/S, Dampfærgevej 22, DK-2100 København Ø, Danska
08228 Tarrasa (Barcelona) Spain 
08228 Tarrasa (Barcelona) Španija
hard capsule 
trda kapsula
Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Ireland 
Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Irska
Actavis Group hf.Reykjavikurvegur 7678 - 220 Hafnarfjörður Iceland 
Actavis Group hf.Reykjavikurvegur 7678 - 220 Hafnarfjörður Islandija
SW1V 2SA United Kingdom 
SW1V 2SA Velika Britanija
Mateo Inurria, 30 28036 Madrid Spain 
Mateo Inurria, 30 28036 Madrid Španija
Luxembourg MEDA PHARMA 25 boulevard de l'amiral Bruix F-75016 Paris France 
Luksemburg MEDA PHARMA 25 boulevard de l'amiral Bruix F-75016 Paris Francija
28042 Madrid Spain 
28042 Madrid Španija
Luxembourg Mylan bvba/sprl Rozendal Businesspark Terhulpsesteenweg 6A B-1560 Hoeilaart Belgium 
Luksemburg Mylan bvba/sprl Rozendal Businesspark Terhulpsesteenweg 6A B-1560 Hoeilaart Belgija
FARMALIDER, S.A. Aragoneses, 15 28108 Madrid Spain 
FARMALIDER, S.A. Aragoneses, 15 28108 Madrid Španija
032266 Bucureşti, Romania codeinum 
032266 Bucureşti, Romunija kodein
Denmark Alternova A/S, Lodshusvej 11, DK4230 Skælskør, Denmark 
Alternova A/S, Lodshusvej 11, DK4230 Skælskør, Danska
Barcelona Spain 
Barcelona Španija
00101 Helsinki Finland 
00101 Helsinki Finska
92300 Levallois-Perret France 
92300 Levallois-Perret Francija
HIPOCRATE 2000 S.R.L. 
Romunija HIPOCRATE 2000 S.R.L.
92517 Boulogne Billancourt Cedex France 
92517 Boulogne Billancourt Cedex Francija
INTERNACIONAL, S.A. Gran Vía Carlos III, 94 08028 Barcelona Spain 
INTERNACIONAL, S.A. Gran Vía Carlos III, 94 08028 Barcelona Španija
00351 Helsinki Finland 
00351 Helsinki Finska
75014 Paris France 
75014 Paris Francija
Denmark Takeda Pharma A/S, Langebjerg 1, DK4000 Roskilde 
Takeda Pharma A/S, Langebjerg 1, DK4000 Roskilde Danska
Seton Products Ltd., Tubiton House, Medlock Street, Oldham, OL1 3HS, United Kingdom 
Seton Products Ltd., Tubiton House, Medlock Street, Oldham, OL1 3HS, Velika Britanija
Clonmel Healthcare Ltd, Waterford Road, Conmel, Co. Tipperary Ireland 
Clonmel Healthcare Ltd, Waterford Road, Conmel, Co. Tipperary Irska
Azur compositum SC Suppositorien suppository rectal use 
Azur compositum SC Suppositorien svečka rektalna uporaba
Nitrianska 100, Hlohovec 920 27 Slovak Republic codeine 
Nitrianska 100, Hlohovec 920 27 Slovaška kodein
de Burgos, 91 28050 Madrid Spain 
de Burgos, 91 28050 Madrid Španija
S.C. Farmacom S.A. Str. Zizinului Nr. 112, 2200 Braşov, 
Str. Zizinului Nr. 112, 2200 Braşov,
Quintanavides, 15 28050 Madrid Spain 
Quintanavides, 15 28050 Madrid Španija
Germany codeine, paracetamol, 
Nemčija kodein, paracetamol,
2610 Wilrijk 
2610 Wilrijk Belgija
LABORATORIOS ERN, S.A. Pedro IV, 499 08022 Barcelona Spain 
LABORATORIOS ERN, S.A. Pedro IV, 499 08022 Barcelona Španija
Str. Prahova, Nr. 6A, Sector 1, Bucureşti 012423, România paracetamol, fosfat de codeină hemihidrat, cafeină anhidră 
Str. Prahova, Nr. 6A, Sector 1, Bucureşti 012423, Romunija paracetamol, kodeinijev fosfat hemihidrat, brezvodni kofein
S.C. SINTOFARM S.A.Str. 
Romunija S.C. SINTOFARM S.A.Str.
S.C. Fabiol S.A, B-dul Timişoara nr. 50, Bucureşti, 
Romunija S.C. Fabiol S.A, B-dul Timişoara nr. 50,
75016 Paris France 
75016 Paris Francija
solution for injection parenteral use 
raztopina za injiciranje parenteralna uporaba
92302 LevalloisPerret Cedex France 
92302 LevalloisPerret Cedex Francija
1170 Brussels Belgium 
1170 Brussels Belgija
Luxembourg bene-Arzneimittel GmbH Herterichstraße 1-3 D-81479 München Germany 
Luksemburg bene-Arzneimittel GmbH Herterichstraße 1-3 D-81479 München Nemčija
851 01 Bratislava Slovak Republic 
Einsteinova 24 851 01 Bratislava Slovaška
08013 Barcelona Spain 
08013 Barcelona Španija
Brentford TW89GS United Kingdom paracetamol, codeine, caffeine 
Brentford TW89GS Velika Britanija paracetamol, kodein, kofein
1080 Brussels Belgium 
1080 Brussels Belgija
Migraleve Pink Filmcoated Tablets. 
Migraleve Pink Filmsko obložena tabletas.
Estrada Consiglieri Pedroso, 69 A - Queluz de Baixo 2730-055 Barcarena Portugal 
A - Queluz de Baixo 2730-055 Barcarena Portugalska
Algocod powder 
Algocod prašek
S.C. Slavia Pharm S.R.L. 
Romunija S.C. Slavia Pharm S.R.L.
08022 Barcelona Spain 
08022 Barcelona Španija
Solpadeine Migraine Ibuprofen & Codeine Tablets film-coated tablet oral use 
Solpadeine Migraine Ibuprofen & Codeine Tablets filmsko obložena tableta
Aspar Pharmaceuticals Limited, 29-30 Capitol Way, Colindale, London NW9 0EQ United Kingdom 
Aspar Pharmaceuticals Limited, 29-30 Capitol Way, Colindale, London NW9 0EQ Velika Britanija kodeinijev fosfat + paracetamol
M&A Pharmachem Limited, Allenby Laboratories, Wigan Road, Westhoughton Bolton BL5 2AL United Kingdom 
M&A Pharmachem Limited, Allenby Laboratories, Wigan Road, Westhoughton Bolton BL5 2AL Velika Britanija
GlaxoSmithKline Consumer Healthcare (Ireland) Limited, Stonemasons Way, Rathfarnham, Dublin 16, Ireland 
GlaxoSmithKline Consumer Healthcare (Ireland) Limited, Stonemasons Way, Rathfarnham, Dublin 16, Irska
Nitrianska 100, Hlohovec 920 27 Slovak Republic acetylsalicylic acid + codeine + caffeine 
Nitrianska 100, Hlohovec 920 27 Slovaška acetilsalicilna kislina + kodein + kofein
GlaxoSmithKline Export Ltd 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom 
GlaxoSmithKline Export Ltd 980 Great West Road Brentford Middlesex TW8 9GS Velika Britanija
1070 Brussels Belgium 
1070 Brussels Belgija
MAX REMEDIES LIMITED, Stoney Gate House, 2 Greenfield Road, Holmfirth, West Yorkshire, HD9 2JT, United Kingdom 
MAX REMEDIES LIMITED, Stoney Gate House, 2 Greenfield Road, Holmfirth, West Yorkshire, HD9 2JT, Velika Britanija kodeinijev fosfat + paracetamol + kofein
LABORATORIES (HOLDINGS)LIMITED, Unit 2A Sefton Business Park, Aintree, Liverpool, L30 1RD, United Kingdom 
LABORATORIES (HOLDINGS)LIMITED, Unit 2A Sefton Business Park, Aintree, Liverpool, L30 1RD, Velika Britanija kodeinijev fosfat + paracetamol
FOURRTS (UK)PHARMACARE LIMITED, 30 Chaul End Lane, Luton, Bedfordshire, LU4 8EZ, United Kingdom 
FOURRTS (UK)PHARMACARE LIMITED, 30 Chaul End Lane, Luton, Bedfordshire, LU4 8EZ, Velika Britanija kodeinijev fosfat + paracetamol
170 09 Solna Sweden codeine hydrochloride dihydrate, papaverine hydrochloride, morphine hydrochloride, hyoscine methonitrate, noscapine hydrochloride 
170 09 Solna Švedska kodeinijev fosfat hemihidrat, papaverinijev klorid, morfinijev klorid, hioscinijev metonitrat, noskapinijev klorid
Bristol Laboratories Limited, Unit 3, Canalside, Northbridge Road, Berkhamsted, Hertfordshire HP4 1EG United Kingdom 
Bristol Laboratories Limited, Unit 3, Canalside, Northbridge Road, Berkhamsted, Hertfordshire HP4 1EG Velika Britanija kodeinijev fosfat
Talvosilen forte 1000/60 1000mg/60 mg suppository rectal use 
Talvosilen forte 1000/60 1000mg/60 mg svečka rektalna uporaba
Great West Road 980 Brentford TW8 9GS United Kingdom 
Great West Road 980 Brentford TW8 9GS Velika Britanija
Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex BN22 9AG, United Kingdom codeine phosphate 
Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex BN22 9AG, Velika Britanija kodeinijev fosfat
182 12 Danderyd Sweden codeine phosphate hemihydrate/ paracetamol 
182 12 Danderyd Švedska kodeinijev fosfat hemihidrat / paracetamol
0,8mg, 40 mg, 13 mg, 0,5 mg, 6 mg suppository rectal use 
0,8mg, 40 mg, 13 mg, 0,5 mg, 6 mg svečka rektalna uporaba
Wockhardt UK Ltd., Ash Road North Wrexham, LL13 9 UF, United Kingdom 
Wockhardt UK Ltd., Ash Road North Wrexham, LL13 9 UF, Velika Britanija
SW1V 2SA United Kingdom paracetamol + codeine Solpadeine Max Tablets 500mg + 12.8mg film-coated tablet oral use 
SW1V 2SA Velika Britanija paracetamol + kodein Solpadeine Max Tablets 500mg + 12.8mg filmsko obložena tableta
paracetamol + codeine Tylex Tablets coated tablet 
paracetamol + kodein Tylex Tablets obložena tableta peroralna uporaba
ENNOGEN PHARMA LIMITED, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS United Kingdom 
ENNOGEN PHARMA LIMITED, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS Velika Britanija kodeinijev fosfat + paracetamol
650 mg and 28,09 mg suppository rectal use 
650 mg and 28,09 mg svečka rektalna uporaba
GEDEON RICHTER ROMÂNIA SA Str. Cuza Vodă nr. 99105, Târgu-Mureş, Romania acid acetilsalicilic, paracetamol , fosfat de codeină hemihidrat , cafeină anhidră 
Str. Cuza Vodă nr. 99105, Târgu-Mureş, Romunija acetilsalicilna kilsina, paracetamol, kodeinijev fosfat hemihidrat, brezvodni kofein
Vitabalans Oy Varastokatu 8, 13500 Hämeenlinna Finland 
Vitabalans Oy Varastokatu 8, 13500 Hämeenlinna Finska
Migraleve Pink Tablets: Paracetamol, codeine phosphate, buclizine hydrochloride 
Migraleve Pink Tablets: Paracetamol, kodeinijev fosfat, buclizinijev klorid
Metamizole sodium/ Paracetamol/ Caffeine/ 
Natrijev metamizolat/ Paracetamol/ Kofein/
Migraleve Yellow Tablets: 520mg, 8mg film-coated tablet oral use 
Migraleve Yellow Tablets: 520mg, 8mg filmsko obložena tableta
Codeine phosphate hemihydrate + ibuprofen 
kodeinijev fosfat hemihidrat + ibuprofen
DOLODENS GRAGEAS 10 mg, 15 mg and 100 mg coated tablet 
DOLODENS GRAGEAS 10 mg, 15 mg and 100 mg obložena tableta peroralna uporaba
Vitabalans Oy Varastokatu 8. 
Madžarska Vitabalans Oy Varastokatu 8.
Ibuprofen and Codeine 200 mg/ 12.8 mg filmcoated Tablets 
Ibuprofen and Codeine 200 mg/ 12.8 mg filmsko obložena tabletas
Soluble Cupanol-Co Lemon Flavour effervescent tablet 
Soluble Cupanol-Co Lemon Flavour šumeča tableta Peroralna uporaba
S.C. LaborMed Pharma S.A.,B-dul Theodor Pallady nr. 44 B,sector 
Romunija S.C. LaborMed Pharma S.A.,B-dul Theodor
170 09 Solna Sweden codeine phosphate hemihydrate 
170 09 Solna Švedska kodeinijev fosfat hemihidrat
Herterichstrasse 1 D-81479 Munchen Germany 
Herterichstrasse 1 D-81479 Munchen Nemčija
Pinex Forte suppository rectal use 
Pinex Forte svečka rektalna uporaba
90429 Nürnberg Germany codeinphosphathemihydrat diclofenac-natrium 
90429 Nürnberg Nemčija kodeinijev fosfat hemihidrat natrijev diklofenakat
The Boots Company Plc, 1 Thane Road West, NG2 3AA, Nottingham United Kingdom 
The Boots Company Plc, 1 Thane Road West, NG2 3AA, Nottingham Velika Britanija
CIPLA (EU) LIMITED, Hillbrow House, Hillbrow Road, Esher, Surrey, KT10 9NW United Kingdom 
CIPLA (EU) LIMITED, Hillbrow House, Hillbrow Road, Esher, Surrey, KT10 9NW Velika Britanija kodeinijev fosfat + paracetamol
Optipyrin suppository rectal use 
Optipyrin svečka rektalna uporaba
paracetamol + codeine Codis 500 Tablets tablet for oral solution 
paracetamol + kodein Codis 500 Tablets tableta za peroralno raztopino
Paracetamol Codeine 
Paracetamol kodein
U kabelovny 130 102 37 Praha 10Dolní Měcholupy Czech Republic 
U kabelovny 130 102 37 Praha 10Dolní Měcholupy Češka
Migraleve Film-coated Tablets 
Migraleve Filmsko obložena tabletas
Brentford TW8 9GS United Kingdom 
Brentford TW8 9GS Velika Britanija
300 mg and 14,05 mg capsule, hard oral use 
300 mg and 14,05 mg kapsula, trda
Tylex 30 mg / 500 mg Hard Capsules capsule, hard oral use 
Tylex 30 mg / 500 mg Hard Capsules kapsula, trda